人工臓器の市場規模、シェア、成長分析、臓器タイプ別、固定法別、エンドユーザー別、地域別 - 産業予測 2025年～2032年

世界の人工臓器市場規模は、2023年に285億米ドルと評価され、2024年の307億5,000万米ドルから2032年には565億米ドルに成長し、予測期間（2025-2032年）のCAGRは7.9％で成長する見通しです。

世界の高齢化は臓器移植の重要性を著しく高めており、特に移植を受ける側であると同時に移植を求める側でもある65歳以上の人々の間で顕著です。この人口統計が増加するにつれて、移植後の合併症リスクが高まることを背景に、補綴器具の需要も増加しています。患者数の増加は、より多くの患者が処置を必要とするため、移植待機者数が増加する可能性があることを示しています。OPTN Modernization Initiativeのようなイノベーションは、臓器移植におけるシステムの効率性とデータの透明性を高めることを目的としています。さらに、3Dバイオプリンティングのような進歩は、拒絶反応のリスクがより低い人工臓器を作成するために支持を集めています。臓器とドナーの適合性評価における人工知能の統合は、回復と患者の受け入れの両方のための意思決定プロセスにおける変革の一歩を意味します。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制分析
• 特許分析

人工臓器市場規模：臓器タイプ別& CAGR（2025-2032）

• 市場概要
• 人工腎臓
• 人工肝臓
• 人工肺
• 人工膵臓
• 人工心臓
• その他の臓器タイプ

人工臓器市場規模：固定法別& CAGR（2025-2032）

• 市場概要
• 埋め込み型
• ウェアラブル

人工臓器市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院
• 学術研究機関
• その他

人工臓器市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• Berlin Heart
• Abbott
• Boston Scientific
• Cochlear
• Edwards Lifesciences
• Ekso Bionics
• Jarvik Heart
• Medtronic
• SynCardia Systems
• Zimmer Biomet
• Wearable Artificial Organs, Inc
• CARMAT
• BiVACOR Inc.
• TransMedics
• Fresenius Medical Care

結論と提言

Global Artificial Organs Market size was valued at USD 28.5 billion in 2023 and is poised to grow from USD 30.75 billion in 2024 to USD 56.5 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).

The global aging population is significantly increasing the importance of organ transplantation, particularly among individuals over 65 who are both recipients and seekers of transplants. As this demographic grows, so does the demand for prosthetic devices, driven by their heightened risk of post-implantation complications. The growing numbers indicate a potential increase in transplant waiting lists as more patients require procedures. Innovations such as the OPTN Modernization Initiative aim to enhance system efficiency and data transparency in organ transplantation. Additionally, advancements like 3D bioprinting are gaining traction for creating artificial organs with a lower risk of rejection. The integration of artificial intelligence in assessing organ and donor compatibility represents a transformative step in decision-making processes for both recovery and patient acceptance.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Artificial Organs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Artificial Organs Market Segments Analysis

Global Artificial Organs Market is segmented by Organ Type, Fixation, End-User and region. Based on Organ Type, the market is segmented into Artificial kidney, Artificial liver, Artificial lungs, Artificial pancreas, Artificial heart and Other organ types. Based on Fixation, the market is segmented into Implantable and Wearable. Based on End-User, the market is segmented into Hospitals, Academic and Research Institutes and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Artificial Organs Market

The Global Artificial Organs market is significantly driven by the rising prevalence of chronic illnesses like kidney failure, heart disease, and liver disease. As more patients experience organ dysfunction, the need for prosthetic organs, including dialysis machines, artificial hearts, and liver support systems, is rapidly increasing. This escalating demand is further accentuated by an aging population and deteriorating quality of life, contributing to an urgent need for life-saving medical interventions. Consequently, the surge in chronic disease cases is propelling the growth of the artificial organs market, highlighting the critical role these technologies play in improving patient outcomes and enhancing overall quality of care.

Restraints in the Global Artificial Organs Market

Although there have been significant advancements in technology, the exorbitant costs associated with prosthetics and related medical procedures continue to hinder the growth of the global artificial organs market. The extensive expenses incurred during the research, development, and manufacturing phases of these devices often render them unaffordable for a large segment of the global population, particularly in developing regions. Consequently, individuals with lower income levels or inadequate access to healthcare services face considerable barriers in obtaining prosthetic solutions. This financial constraint significantly restricts the reach and effectiveness of artificial organs, limiting their availability to those who need them the most.

Market Trends of the Global Artificial Organs Market

The Global Artificial Organs market is witnessing a significant trend driven by the integration of 3D printing technology in prosthetics. This innovation allows for the creation of customized, patient-specific organs that enhance accuracy, functionality, and biocompatibility, addressing individual healthcare needs more effectively. The ability to rapidly produce high-quality prosthetics at lower costs not only increases accessibility but also accelerates the manufacturing process, making 3D printing a pivotal segment within the market. As a result, stakeholders are increasingly investing in this technology, anticipating its role in reshaping healthcare solutions and improving the quality of life for patients worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Patent Analysis

Global Artificial Organs Market Size by Organ Type & CAGR (2025-2032)

• Market Overview
• Artificial kidney
• Artificial liver
• Artificial lungs
• Artificial pancreas
• Artificial heart
• Other organ types

Global Artificial Organs Market Size by Fixation & CAGR (2025-2032)

• Market Overview
• Implantable
• Wearable

Global Artificial Organs Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Academic and Research Institutes
• Others

Global Artificial Organs Market Size & CAGR (2025-2032)

• North America (Organ Type, Fixation, End-User)
  • US
  • Canada
• Europe (Organ Type, Fixation, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Organ Type, Fixation, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Organ Type, Fixation, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Organ Type, Fixation, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Berlin Heart
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cochlear
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ekso Bionics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jarvik Heart
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SynCardia Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wearable Artificial Organs, Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CARMAT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BiVACOR Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TransMedics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations